Brain Neoplasms; Glioma; Meningioma; Neurosurgery; Radiculopathy; Neurosurgical Procedures; Anti-Glomerular Basement Membrane Disease; Individualized Medicine
Dr. Moliterno's interest is in taking important findings discovered in the lab (i.e. underlying genetic mutations of tumors) and applying them to patient care through clinical trials.
Specialized Terms: Clinical trials for brain tumors; Personalized medicine for patients with brain tumors; Brain tumors
Improvement in pain after lumbar surgery in cancer patients with mechanical radiculopathy.
Improvement in pain after lumbar surgery in cancer patients with mechanical radiculopathy. Moliterno J, Veselis CA, Hershey MA, Lis E, Laufer I, Bilsky MH. Spine J. 2014 Oct 1;14(10):2434-9. doi: 10.1016/j.spinee.2014.03.006. Epub 2014 Mar 12.
Molecular and genetic pathways in gliomas: the future of personalized therapeutics.
Molecular and genetic pathways in gliomas: the future of personalized therapeutics. Grant R, Kolb L, Moliterno J. CNS Oncol. 2014 Mar;3(2):123-36. doi: 10.2217/cns.14.7.
Full List of PubMed Publications
- Erson-Omay EZ, Çağlayan AO, Schultz N, Weinhold N, Omay SB, Özduman K, Köksal Y, Li J, Serin Harmancı A, Clark V, Carrión-Grant G, Baranoski J, Çağlar C, Barak T, Coşkun S, Baran B, Köse D, Sun J, Bakırcıoğlu M, Moliterno Günel J, Pamir MN, Mishra-Gorur K, Bilguvar K, Yasuno K, Vortmeyer A, Huttner AJ, Sander C, Günel M: Somatic POLE mutations cause an ultramutated giant cell high-grade glioma subtype with better prognosis. Neuro Oncol. 2015 Oct; 2015 Mar 3. PMID: 25740784